ESC Premium Access

Emerging evidence for SGLT2i in HFrEF patients.

Congress Session

About the speaker

Doctor Prasant Kumar Sahoo

Bhubaneswar (India)
1 presentation
0 follower

3 more presentations in this session

Welcome and introduction.

Speaker: Professor C. Lam (Singapore, SG)

Thumbnail

SGLT2i in ESC 2021 HF management guideline - clinical implication.

Speaker: Doctor J. Kang (Seoul, KR)

Thumbnail

Discussion and live Q&A.

Thumbnail

Access the full session

Evolving role of SGLT2i in HFrEF management

Speakers: Doctor P. Kumar Sahoo, Professor C. Lam, Doctor J. Kang
Thumbnail

About the event

Image

ESC Asia with APSC & AFC 2021

2 December - 4 December 2021

Sessions Presentations

Related content

Open Access

Hot topics in atrial fibrillation.

5 April 2022

ESC Premium Access

Intermittent therapy with levosimendan in patients with advanced heart failure

27 August 2021

ESC Premium Access

Ticagrelor implementation in PCI-treated ACS patients

27 August 2021

This platform is supported by

logo Novo Nordisk